cbdMD, Inc. produces and distributes various cannibidiol (CBD) products in the United States. It operates through three segments: Products, Licensing, and Entertainment. The Products segment produces and markets CBD tinctures, capsules, gummies, bath bombs, vape oils, topical creams, and animal treats and oils under the cdbMD brand. The Licensing segment establishes brands through licensing of select products/categories focusing on health and wellness, and men's lifestyle products. The Entertainment segment produces and markets various entertainment distribution platforms under the EE1 brand. This segment offers recordings, film, TV, Web and live events, and entertainment experiences; and brand management services, including creative development and marketing, brand strategy, and distribution support. cbdMD, Inc. also provides hair care products, including shampoos, conditioners, styling aides, and a patented styling tool through retailers and online outlets. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is based in Charlotte, North Carolina.
Industry, Sector and Symbol
Industry Marketing Services
Sub-IndustryN/A
SectorConsumer Cyclical
CIKN/A
Phone704-445-5800
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees50
Next Earnings Date5/20/2020 (Estimated)
OptionableNot Optionable
cbdMD (NYSEAMERICAN:YCBD) Frequently Asked Questions
What is cbdMD's stock symbol?
cbdMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "YCBD."
How were cbdMD's earnings last quarter?
cbdMD, Inc. (NYSEAMERICAN:YCBD) issued its quarterly earnings results on Thursday, February, 13th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.15) by $0.61. The business earned $10.41 million during the quarter. View cbdMD's Earnings History.
When is cbdMD's next earnings date?
What guidance has cbdMD issued on next quarter's earnings?
cbdMD updated its FY 2020
After-Hours earnings guidance on Wednesday, December, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $62-70 million, compared to the consensus revenue estimate of $72.81 million.
What price target have analysts set for YCBD?
2 equities research analysts have issued 12-month price objectives for cbdMD's stock. Their forecasts range from $7.00 to $7.00. On average, they anticipate cbdMD's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 503.4% from the stock's current price. View Analyst Price Targets for cbdMD.
What is the consensus analysts' recommendation for cbdMD?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for cbdMD in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for cbdMD.
Has cbdMD been receiving favorable news coverage?
Headlines about YCBD stock have trended extremely negative recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. cbdMD earned a news impact score of -5.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for cbdMD.
Are investors shorting cbdMD?
cbdMD saw a decline in short interest in January. As of January 31st, there was short interest totalling 993,100 shares, a decline of 60.9% from the January 15th total of 2,540,000 shares. Based on an average daily trading volume, of 514,800 shares, the days-to-cover ratio is presently 1.9 days. Approximately 8.5% of the shares of the stock are sold short. View cbdMD's Current Options Chain.
Who are some of cbdMD's key competitors?
Some companies that are related to cbdMD include GTN (GTN), Salmat (SLM), Taptica International (TAP), Cello Health (CLL), Trimantium Growthops (TGO), I Synergy Group (IS3), Arena Events Group (ARE), System1 Group (SYS1), NAHL Group (NAH), Ebiquity (EBQ), Tech Mpire (TMP), Inuvo (INUV), Inuvo (INUV), Engage:BDR (EN1) and Be Heard Group (BHRD).
What other stocks do shareholders of cbdMD own?
Who are cbdMD's major shareholders?
cbdMD's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include AdvisorShares Investments LLC (1.34%), State Street Corp (0.37%), Lionsbridge Wealth Management LLC (0.34%), Oxford Asset Management LLP (0.05%) and Spark Investment Management LLC (0.05%). Company insiders that own cbdMD stock include Bakari T Sellers, Mark S Elliott and Raymond Scott Coffman. View Institutional Ownership Trends for cbdMD.
Which major investors are selling cbdMD stock?
Which major investors are buying cbdMD stock?
YCBD stock was acquired by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Lionsbridge Wealth Management LLC, Oxford Asset Management LLP and State Street Corp. Company insiders that have bought cbdMD stock in the last two years include Bakari T Sellers, Mark S Elliott and Raymond Scott Coffman. View Insider Buying and Selling for cbdMD.
How do I buy shares of cbdMD?
Shares of YCBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is cbdMD's stock price today?
One share of YCBD stock can currently be purchased for approximately $1.16.
How big of a company is cbdMD?
What is cbdMD's official website?
How can I contact cbdMD?
The company can be reached via phone at 704-445-5800.
MarketBeat Community Rating for cbdMD (NYSEAMERICAN YCBD)
MarketBeat's community ratings are surveys of what our community members think about cbdMD and other stocks. Vote "Outperform" if you believe YCBD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe YCBD will underperform the S&P 500 over the long term. You may vote once every thirty days.
